Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis
BJU International · 2023-06 · 131 (6) · 729-733
DOI: 10.1111/bju.15960 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, online erschienen am 06.03.2023. Verfasst von Steven K Wilson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute for Urologic Excellence, La Quinta, CA, USA. Hauptthemen laut MEDLINE: Penile Prosthesis, Penile Implantation, Penile Induration, Erectile Dysfunction. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Objective
To analyse data from patient information forms (PIFs) submitted to the manufacturer of a new three‐piece inflatable penile prosthesis (IPP), the Rigicon Infla10®, to summarize early outcomes.
Methods
A retrospective review of PIFs from 319 patients implanted with the IPP between 6 January 2019 and 31 December 2021 was performed to assess device durability and rates of reoperation for infection, mechanical failure or medical reasons.
Results
The mean ± sd (range) follow‐up was 21.2 ± 11 (5–36) months and the mean ± sd patient age was 58.5 ± 8.7 years. Of the total, 4.4% of devices required removal or revision. Complications included mechanical failure (2.5%) and component migration (0.7%). No infections were observed in this series. One patient (0.4%) required revision for inadequate straightening of Peyronie's disease. Three patients (0.9%) requested device removal because of dissatisfaction. A total of 95.6% of the Rigicon Infla10 devices were free from explant or revision 21 months after the original implant date. Kaplan–Meier analysis showed the rates of cumulative survival of the device at 12, 24, 36 months were 95.6%, 94.7% and 93.7%, respectively.
Conclusions
The vast majority of the early Rigicon Infla10 IPPs implanted prior to January 2022 were included in this retrospective analysis of volunteered PIFs. These early results demonstrate initial durability from reoperation equivalent to that of other contemporary devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Institute for Urologic Excellence, La Quinta, CA, USA.
- Department of Urology, Mayo Clinic, Rochester, MN, USA.
- Department of Andrology, Instituto Medico Rossello, Palma De Majorca & Madrid, Spain.
- Department of Urology, Montefiori Medical Center, Bronx, NY, USA.
- Department of Urology, University of South Florida, Tampa, FL, USA.
- Department of Urology, Perito Urology, Coral Gables, FL, USA.
ORCID-Profile: Lexiaochuan Wen
Zitieren
APA
Wilson, S. K., Wen, L., Rossello, M., Maria, P., Carrion, R., Perito, P., Ralph, D., Antonini, G., Carvajal, A., Ozturk, M. I., & Chung, E. (2023). Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis. BJU International, 131(6), 729-733. https://doi.org/10.1111/bju.15960
Vancouver
Wilson SK, Wen L, Rossello M, Maria P, Carrion R, Perito P, et al. Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis. BJU International. 2023;131(6):729-733. doi:10.1111/bju.15960
BibTeX
@article{Wilson2023,
author = {Wilson, Steven K and Wen, Lexiaochuan and Rossello, Mariano and Maria, Pedro and Carrion, Rafael and Perito, Paul and Ralph, David and Antonini, Gabriele and Carvajal, Alejandro and Ozturk, Metin I and Chung, Eric},
title = {Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis},
journal = {BJU International},
year = {2023},
volume = {131},
number = {6},
pages = {729--733},
doi = {10.1111/bju.15960}
}
EUVIMED